Pfizer Company Executives
PFE Stock | 12.17 0.10 0.83% |
Pfizer employs about 88 K people. The company is managed by 18 executives with a total tenure of roughly 205334 years, averaging almost 11407.0 years of service per executive, having 4888.89 employees per reported executive. Analysis of Pfizer's management performance can provide insight into the firm performance.
Pfizer |
Pfizer Management Team Effectiveness
The company has return on total asset (ROA) of 0.0331 % which means that it generated a profit of $0.0331 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0454 %, meaning that it generated $0.0454 on every $100 dollars invested by stockholders. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Pfizer's Net Tangible Assets are very stable compared to the past year. As of the 2nd of December 2024, Total Current Assets is likely to grow to about 49.9 B, while Total Assets are likely to drop about 199.2 B.As of the 2nd of December 2024, Common Stock Shares Outstanding is likely to drop to about 4.5 B. In addition to that, Net Income Applicable To Common Shares is likely to drop to about 19.7 B
Pfizer Workforce Comparison
Pfizer Inc CDR is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 89,277. Pfizer totals roughly 88,000 in number of employees claiming about 99% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33. Pfizer Inc CDR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pfizer Inc CDR Price Series Summation is a cross summation of Pfizer price series and its benchmark/peer.
Pfizer Notable Stakeholders
A Pfizer stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pfizer often face trade-offs trying to please all of them. Pfizer's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pfizer's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Albert DVM | Chairman CEO | Profile | |
Payal Becher | Chief VP | Profile | |
John Young | Advisor | Profile | |
Jennifer Damico | Controller VP | Profile | |
Aamir Malik | Executive Officer | Profile | |
DVM DVM | Chairman CEO | Profile | |
Frank DAmelio | CFO VP | Profile | |
Sally Susman | Executive Officer | Profile | |
Douglas Lankler | Executive Counsel | Profile | |
Rady Johnson | Quality Compliance | Profile | |
Mikael MD | Chief Development | Profile | |
Christopher CFA | VP Officer | Profile | |
Andreas Panayiotou | Global Officer | Profile | |
Francesca DeMartino | Chief Officer | Profile | |
Lidia Fonseca | Executive Officer | Profile | |
Angela Hwang | Chief Bus | Profile | |
David Denton | Chief VP | Profile | |
Annette Doherty | Head Sciences | Profile |
About Pfizer Management Performance
The success or failure of an entity such as Pfizer Inc CDR often depends on how effective the management is. Pfizer management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pfizer management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pfizer management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pfizer is entity of Canada. It is traded as Stock on NEO exchange.
Pfizer Workforce Analysis
Traditionally, organizations such as Pfizer use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pfizer within its industry.Pfizer Manpower Efficiency
Return on Pfizer Manpower
Revenue Per Employee | 664.7K | |
Revenue Per Executive | 3.2B | |
Net Income Per Employee | 24.1K | |
Net Income Per Executive | 117.7M |
Other Information on Investing in Pfizer Stock
Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.